Even though TMPRSS2-ERG rearrangement is considered an early event in human prostate tumorigenesis, several in vitro and in vivo studies exclude functional roles of ERG in PCa onset but associate ERG activity to tumor progression by providing cancer cells with migratory and invasive molecular competences34–36. Here, TMPRSS2 is linked to cancer.